查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1891475

注射笔针市场规模、占有率、成长及全球产业分析：依类型、应用和地区划分的洞察与预测（2024-2032）

Pen Needles Market Size, Share, Growth and Global Industry Analysis By Type & Application, Regional Insights and Forecast, 2024-2032
出版日期: | 出版商: Fortune Business Insights Pvt. Ltd. | 英文 130 Pages | 商品交期: 请询问到货日

价格

注射笔针市场成长驱动因素

受需要注射治疗的慢性病患者数量增加的推动，全球注射笔针市场持续快速成长。根据最新的产业数据，预计该市场规模将在2024年达到22.8亿美元，2025年达到24.1亿美元。预计2032年将进一步成长至38.9亿美元，在预测期内维持7.0%的稳定复合年增长率。北美地区在2024年继续保持领先市场地位，占39.47%的显着市场。这得归功于其完善的基础设施、注射给药装置的高渗透率以及各种先进註射笔针品牌的广泛供应。

注射笔在需要定期注射的疾病（例如糖尿病、骨质疏鬆症和生长激素缺乏症）的患者自我治疗中发挥着至关重要的作用。频繁更换（通常每天或多次使用后）确保了市场需求的持续成长。对注射笔给药解决方案日益增长的依赖性显着推动了市场规模的扩大。 Ypsomed 报告称，2023 年 UnoPen 和 YpsoPen 的需求量创下历史新高，销售量分别超过 1 亿支和 1000 万支，反映了全球注射笔药物的消费趋势。

市场趋势

影响市场发展的关键趋势是，业内企业越来越重视改善给药系统。製造商正在推出改良型产品，以提高使用者的安全性、舒适性和易用性。例如，2022 年 9 月，诺和诺德公司推出了其 Tresiba 注射笔的仿製药，提高了糖尿病患者的用药便利性。此外，各公司正在扩大产品供应范围。 2024年4月，MTD Medical Technology and Devices S.p.A. 在美国推出了非处方（OTC）的Droplet Micron胰岛素笔针，透过线上药局和零售通路扩大了消费者的购买管道。

成长因素

全球代谢和内分泌疾病的增加仍然是市场的主要驱动因素。截至2021年，20至79岁成年人中糖尿病盛行率为10.5%，预计2045年这一数字将增加46%，这将增强对胰岛素笔和笔针的长期需求。骨质疏鬆症也是一个重要的驱动因素。预计到2023年，美国50至64岁女性的盛行率为13.1%，65岁及以上女性的盛行率为27.5%，将增加对注射疗法的需求。市场参与者正在不断扩大其产品组合以满足这一需求。例如，2024年3月，MTD收购了Ypsomed的胰岛素笔针和血糖监测业务，增强了其产品能力和全球影响力。

市场限制因子

儘管需求强劲，但仍存在一些阻碍市场成长的因素。胰岛素笔针有註射部位反应的风险，例如脂肪增生、皮肤感染和过敏，这些反应通常是由于注射技术不佳造成的。医护人员也面临暴露风险。根据2023年的一项研究，中国有3.2%的护理师因针刺伤而感染B型肝炎病毒（HBV）。此外，口服药物等替代疗法的出现，也为注射给药装置市场带来了竞争压力。

细分市场概览

2024年，由于糖尿病的高发生率和人们对针刺伤风险认识不足，标准胰岛素笔针在产品类型细分市场中占主导地位。同时，由于对安全功能的需求不断增长，安全型胰岛素笔针预计将实现最快成长。

依药物类型划分，胰岛素市场将在2024年占最大占有率，这反映了全球糖尿病患者数量庞大。先进注射解决方案的出现，例如Civica与Ypsomed合作于2023年推出的低成本胰岛素笔，将继续推动市场成长。

依疾病类型划分，糖尿病在2024年仍将是领先领域。新产品的获批，例如诺和诺德的基础胰岛素Awiqli（Icodec），将于2024年获批，这将进一步推动该领域的扩张。预计到 2022 年，全球肥胖率将达到八分之一，这将推动肥胖症治疗领域强劲成长。

针头尺寸正朝着更短、更安全的方向发展，4 毫米针头预计将于 2024 年成为主流，因为它可以降低肌肉注射的风险。 6 毫米针头预计将实现最快增长，因为它可以提高注射舒适度。

区域展望

2024 年，北美市场将继续保持领先地位，估值达 9 亿美元，这主要得益于 Embecta、Cardinal Health 和 Allison Medical 等领先製造商的推动。欧洲也蕴藏着巨大的潜力，这主要得益于糖尿病的高发生率，例如到2024年，英国的糖尿病患者将达到430万例。亚太地区预计将实现最快的成长，这得益于先进注射疗法的不断涌现，例如赛诺菲计划于2024年在印度推出Soliqua。拉丁美洲以及中东和非洲地区也展现出良好的发展前景，这也得益于糖尿病的高发生率，例如2021年巴西有1570万成年人患有糖尿病。

目录

第一章：引言

第二章：摘要整理

第三章：市场动态

  • 市场驱动因素
  • 市场限制因素
  • 市场机遇
  • 市场趋势

章节4：主要发现

  • 2024年主要国家和地区糖尿病盛行率
  • 2024年主要国家及地区肥胖盛行率
  • 主要产业趋势（併购、合作等）
  • 新冠疫情对市场的影响

第五章：全球胰岛素笔针市场分析、洞察与预测（2019-2032）

  • 依产品类型划分的市场分析、洞察与预测
    • 标准胰岛素笔针
    • 安全胰岛素笔针
  • 依药物类型划分的市场分析、洞察与预测
    • 胰岛素
    • GLP-1
    • 增长激素
    • 其他
  • 市场分析、洞察与预测 - 依疾病分类
    • 糖尿病
    • 肥胖症
    • 荷尔蒙缺乏症
    • 其他
  • 市场分析、洞察与预测 - 依针头尺寸分类
    • 4 毫米
    • 5 毫米
    • 6 毫米
    • 8 毫米
    • 12 毫米
  • 市场分析、洞察与预测 - 依销售管道分类
    • 医院药房
    • 零售药房
    • 线上药房
  • 市场分析、洞察与预测 - 依地区分类
    • 北美
    • 欧洲
    • 亚太地区
    • 拉丁美洲
    • 中东和非洲

第六章：北美注射笔针市场分析、洞察与预测（2019-2032）

  • 依国家划分
    • 美国
    • 加拿大

第七章：欧洲注射笔针市场分析、洞察与预测（2019-2032）

  • 依国家划分
    • 英国
    • 德国
    • 法国
    • 西班牙
    • 义大利
    • 斯堪的纳维亚半岛
    • 欧洲其他地区

第八章：亚太地区注射笔针市场分析、洞察与预测（2019-2032）

  • 依国家/地区
    • 日本
    • 中国
    • 澳大利亚
    • 印度
    • 东南亚
    • 亚太其他地区

第九章：拉丁美洲注射笔针市场分析、洞察与预测（2019-2032）

  • 依国家划分
    • 巴西
    • 墨西哥
    • 拉丁美洲其他地区

第十章：中东与非洲注射笔针市场分析、洞察与预测（2019-2032）

  • 依国家划分
    • 南非
    • 海湾合作委员会
    • 拉丁美洲其他地区

第十一章：竞争格局分析

  • 全球市占率分析（2024）
  • 公司简介
    • 诺和诺德公司
    • Embecta公司
    • 贝朗公司
    • 欧文·芒福德公司
    • BD公司
    • 康德乐公司
    • SOL-Millennium公司
    • 泰尔茂株式会社
    • MTD医疗技术与设备公司
    • UltiMed公司
    • Allison Medical公司
Product Code: FBI110437

Growth Factors of pen needles Market

The global pen needles market continues to expand rapidly, driven by the rising prevalence of chronic conditions requiring injectable therapies. According to recent industry data, the market was valued at USD 2.28 billion in 2024 and is projected to reach USD 2.41 billion in 2025, eventually climbing to USD 3.89 billion by 2032, reflecting a steady CAGR of 7.0% over the forecast period. North America remained the dominant regional market in 2024 with a significant 39.47% share, supported by strong infrastructure, high adoption of injectable drug delivery devices, and widespread availability of advanced pen needle brands.

Pen needles play an essential role in patient-administered therapies, particularly for diseases requiring regular injections, such as diabetes, osteoporosis, and growth hormone deficiencies. Their frequent replacement-often daily or after several uses-ensures continuous market demand. Increasing reliance on pen-based drug delivery solutions is a major contributor to the expanding market base. In 2023, Ypsomed reported record demand for UnoPen and YpsoPen, exceeding 100 million and 10 million units sold, respectively, reflecting global consumption patterns for pen-based injectables.

Market Trends

A key trend influencing market development is the growing focus on improved drug delivery systems by industry players. Manufacturers are launching enhanced products that improve user safety, comfort, and access. For example, in September 2022, Novo Nordisk A/S introduced a generic version of its Tresiba injection pen, increasing accessibility for diabetic patients. Additionally, companies are expanding product availability: in April 2024, MTD Medical Technology and Devices S.p.A. made its Droplet Micron pen needles available over-the-counter in the U.S., broadening consumer access through online pharmacies and retail channels.

Growth Factors

The rising global burden of metabolic and hormonal disorders remains the leading market driver. Diabetes prevalence reached 10.5% of adults aged 20-79 years in 2021, with figures projected to rise by 46% by 2045, reinforcing long-term demand for insulin pens and pen needles. Osteoporosis is also a major contributor: in 2023, 13.1% of U.S. women aged 50-64 and 27.5% of women aged 65+ were affected, elevating the need for injectable treatments. Market players continue to expand their portfolios to meet this demand. For example, in March 2024, MTD acquired Ypsomed's pen needle and blood glucose monitoring businesses, advancing its product capabilities and global reach.

Restraints

Despite strong demand trends, certain factors hinder market growth. Pen needles carry risks of site reactions such as lipohypertrophy, skin infections, and allergies, often triggered by poor injection techniques. Healthcare providers also face exposure risks: a study reported in 2023 indicated 3.2% of nurses in China experienced HBV infections linked to needlestick injuries. Additionally, availability of alternative therapies-such as oral medications-places competitive pressure on injectable delivery device markets.

Segmentation Overview

Standard pen needles dominated the product type segment in 2024, driven by high diabetes prevalence and lower awareness of needlestick hazards. Conversely, safety pen needles are expected to grow at the fastest pace due to rising demand for injury prevention features.

Among drug types, the insulin segment held the largest share in 2024, reflecting the substantial global diabetic population. The launch of advanced injectable solutions, such as affordable insulin pens introduced through the 2023 Civica-Ypsomed partnership, continues to propel the market.

Based on disease indication, diabetes remained the leading segment in 2024. New product approvals, such as Novo Nordisk's 2024 regulatory clearance for Awiqli basal insulin icodec, further support segment expansion. The obesity segment is also poised for strong growth, supported by global obesity levels estimated at one in eight people in 2022.

Needle sizes are shifting toward shorter, safer formats, with 4 mm needles dominating 2024 due to reduced intramuscular injection risks. The 6 mm category is expected to grow fastest, attributed to improved injection comfort.

Regional Outlook

North America led the market in 2024 with a valuation of USD 0.90 billion, attributed to major manufacturers such as Embecta, Cardinal Health, and Allison Medical. Europe also holds substantial potential, driven by high diabetes prevalence, including 4.3 million cases in the U.K. in 2024. Asia Pacific is expected to grow fastest due to rising launches of advanced injection therapies, such as Sanofi's 2024 introduction of Soliqua in India. Latin America and the Middle East & Africa show promising prospects due to high diabetes rates, including 15.7 million adults affected in Brazil in 2021.

Conclusion

With rising global prevalence of chronic diseases, advancements in drug delivery systems, and increasing accessibility of injectable therapies, the pen needles market is set for sustained expansion, reaching USD 3.89 billion by 2032.

Segmentation By Product Type

  • Standard Pen Needles
  • Safety Pen Needles

By Drug Type

  • Insulin
  • GLP-1
  • Growth Hormone
  • Others

By Disease Indication

  • Diabetes
  • Obesity
  • Hormone Deficiency
  • Others

By Needle Size

  • 4 mm
  • 5 mm
  • 6 mm
  • 8 mm
  • 12 mm

By Distribution Channel

  • Hospital Pharmacy
  • Retail Pharmacy
  • Online Pharmacy

By Region

  • North America (By Product Type, By Drug Type, By Disease Indication, By Needle Size, By Distribution Channel, and By Country)
    • U.S.
    • Canada
  • Europe (By Product Type, By Drug Type, By Disease Indication, By Needle Size, By Distribution Channel, and by Country/Sub-region)
    • U.K.
    • Germany
    • France
    • Spain
    • Italy
    • Scandinavia
    • Rest of Europe
  • Asia Pacific (By Product Type, By Drug Type, By Disease Indication, By Needle Size, By Distribution Channel, and by Country/Sub-region)
    • Japan
    • China
    • Australia
    • India
    • Southeast Asia
    • Rest of Asia Pacific
  • Latin America (By Product Type, By Drug Type, By Disease Indication, By Needle Size, By Distribution Channel, and by Country/Sub-region)
    • Brazil
    • Mexico
    • Rest of Latin America
  • Middle East & Africa (By Product Type, By Drug Type, By Disease Indication, By Needle Size, By Distribution Channel, and by Country/Sub-region)
    • South Africa
    • GCC
  • Rest of Middle East & Africa

Table of Content

1. Introduction

  • 1.1. Research Scope
  • 1.2. Market Segmentation
  • 1.3. Research Methodology
  • 1.4. Definitions and Assumptions

2. Executive Summary

3. Market Dynamics

  • 3.1. Market Drivers
  • 3.2. Market Restraints
  • 3.3. Market Opportunities
  • 3.4. Market Trends

4. Key Insights

  • 4.1. Prevalence of Diabetes - by Key Countries/Regions, 2024
  • 4.2. Prevalence of Obesity - by Key Countries/Regions, 2024
  • 4.3. Key Industry Developments (Mergers, Acquisitions, Partnerships, etc.)
  • 4.4. Impact of COVID-19 on the Market

5. Global Pen Needles Market Analysis, Insights and Forecast, 2019-2032

  • 5.1. Market Analysis, Insights and Forecast - By Product Type
    • 5.1.1. Standard Pen Needles
    • 5.1.2. Safety Pen Needles
  • 5.2. Market Analysis, Insights and Forecast - By Drug Type
    • 5.2.1. Insulin
    • 5.2.2. GLP-1
    • 5.2.3. Growth Hormone
    • 5.2.4. Others
  • 5.3. Market Analysis, Insights and Forecast - By Disease Indication
    • 5.3.1. Diabetes
    • 5.3.2. Obesity
    • 5.3.3. Hormone Deficiency
    • 5.3.4. Others
  • 5.4. Market Analysis, Insights and Forecast - By Needle Size
    • 5.4.1. 4 mm
    • 5.4.2. 5 mm
    • 5.4.3. 6 mm
    • 5.4.4. 8 mm
    • 5.4.5. 12 mm
  • 5.5. Market Analysis, Insights and Forecast - By Distribution Channel
    • 5.5.1. Hospital Pharmacy
    • 5.5.2. Retail Pharmacy
    • 5.5.3. Online Pharmacy
  • 5.6. Market Analysis, Insights and Forecast - By Region
    • 5.6.1. North America
    • 5.6.2. Europe
    • 5.6.3. Asia Pacific
    • 5.6.4. Latin America
    • 5.6.5. Middle East & Africa

6. North America Pen Needles Market Analysis, Insights and Forecast, 2019-2032

  • 6.1. Market Analysis, Insights and Forecast - By Product Type
    • 6.1.1. Standard Pen Needles
    • 6.1.2. Safety Pen Needles
  • 6.2. Market Analysis, Insights and Forecast - By Drug Type
    • 6.2.1. Insulin
    • 6.2.2. GLP-1
    • 6.2.3. Growth Hormone
    • 6.2.4. Others
  • 6.3. Market Analysis, Insights and Forecast - By Disease Indication
    • 6.3.1. Diabetes
    • 6.3.2. Obesity
    • 6.3.3. Hormone Deficiency
    • 6.3.4. Others
  • 6.4. Market Analysis, Insights and Forecast - By Needle Size
    • 6.4.1. 4 mm
    • 6.4.2. 5 mm
    • 6.4.3. 6 mm
    • 6.4.4. 8 mm
    • 6.4.5. 12 mm
  • 6.5. Market Analysis, Insights and Forecast - By Distribution Channel
    • 6.5.1. Hospital Pharmacy
    • 6.5.2. Retail Pharmacy
    • 6.5.3. Online Pharmacy
  • 6.6. Market Analysis, Insights and Forecast - By Country
    • 6.6.1. U.S.
    • 6.6.2. Canada

7. Europe Pen Needles Market Analysis, Insights and Forecast, 2019-2032

  • 7.1. Market Analysis, Insights and Forecast - By Product Type
    • 7.1.1. Standard Pen Needles
    • 7.1.2. Safety Pen Needles
  • 7.2. Market Analysis, Insights and Forecast - By Drug Type
    • 7.2.1. Insulin
    • 7.2.2. GLP-1
    • 7.2.3. Growth Hormone
    • 7.2.4. Others
  • 7.3. Market Analysis, Insights and Forecast - By Disease Indication
    • 7.3.1. Diabetes
    • 7.3.2. Obesity
    • 7.3.3. Hormone Deficiency
    • 7.3.4. Others
  • 7.4. Market Analysis, Insights and Forecast - By Needle Size
    • 7.4.1. 4 mm
    • 7.4.2. 5 mm
    • 7.4.3. 6 mm
    • 7.4.4. 8 mm
    • 7.4.5. 12 mm
  • 7.5. Market Analysis, Insights and Forecast - By Distribution Channel
    • 7.5.1. Hospital Pharmacy
    • 7.5.2. Retail Pharmacy
    • 7.5.3. Online Pharmacy
  • 7.6. Market Analysis, Insights and Forecast - By Country/ Sub-region
    • 7.6.1. U.K.
    • 7.6.2. Germany
    • 7.6.3. France
    • 7.6.4. Spain
    • 7.6.5. Italy
    • 7.6.6. Scandinavia
    • 7.6.7. Rest of Europe

8. Asia Pacific Pen Needles Market Analysis, Insights and Forecast, 2019-2032

  • 8.1. Market Analysis, Insights and Forecast - By Product Type
    • 8.1.1. Standard Pen Needles
    • 8.1.2. Safety Pen Needles
  • 8.2. Market Analysis, Insights and Forecast - By Drug Type
    • 8.2.1. Insulin
    • 8.2.2. GLP-1
    • 8.2.3. Growth Hormone
    • 8.2.4. Others
  • 8.3. Market Analysis, Insights and Forecast - By Disease Indication
    • 8.3.1. Diabetes
    • 8.3.2. Obesity
    • 8.3.3. Hormone Deficiency
    • 8.3.4. Others
  • 8.4. Market Analysis, Insights and Forecast - By Needle Size
    • 8.4.1. 4 mm
    • 8.4.2. 5 mm
    • 8.4.3. 6 mm
    • 8.4.4. 8 mm
    • 8.4.5. 12 mm
  • 8.5. Market Analysis, Insights and Forecast - By Distribution Channel
    • 8.5.1. Hospital Pharmacy
    • 8.5.2. Retail Pharmacy
    • 8.5.3. Online Pharmacy
  • 8.6. Market Analysis, Insights and Forecast - By Country/Sub-region
    • 8.6.1. Japan
    • 8.6.2. China
    • 8.6.3. Australia
    • 8.6.4. India
    • 8.6.5. Southeast Asia
    • 8.6.6. Rest of Asia Pacific

9. Latin America Pen Needles Market Analysis, Insights and Forecast, 2019-2032

  • 9.1. Market Analysis, Insights and Forecast - By Product Type
    • 9.1.1. Standard Pen Needles
    • 9.1.2. Safety Pen Needles
  • 9.2. Market Analysis, Insights and Forecast - By Drug Type
    • 9.2.1. Insulin
    • 9.2.2. GLP-1
    • 9.2.3. Growth Hormone
    • 9.2.4. Others
  • 9.3. Market Analysis, Insights and Forecast - By Disease Indication
    • 9.3.1. Diabetes
    • 9.3.2. Obesity
    • 9.3.3. Hormone Deficiency
    • 9.3.4. Others
  • 9.4. Market Analysis, Insights and Forecast - By Needle Size
    • 9.4.1. 4 mm
    • 9.4.2. 5 mm
    • 9.4.3. 6 mm
    • 9.4.4. 8 mm
    • 9.4.5. 12 mm
  • 9.5. Market Analysis, Insights and Forecast - By Distribution Channel
    • 9.5.1. Hospital Pharmacy
    • 9.5.2. Retail Pharmacy
    • 9.5.3. Online Pharmacy
  • 9.6. Market Analysis, Insights and Forecast - By Country/Sub-region
    • 9.6.1. Brazil
    • 9.6.2. Mexico
    • 9.6.3. Rest of Latin America

10. Middle East & Africa Pen Needles Market Analysis, Insights and Forecast, 2019-2032

  • 10.1. Market Analysis, Insights and Forecast - By Product Type
    • 10.1.1. Standard Pen Needles
    • 10.1.2. Safety Pen Needles
  • 10.2. Market Analysis, Insights and Forecast - By Drug Type
    • 10.2.1. Insulin
    • 10.2.2. GLP-1
    • 10.2.3. Growth Hormone
    • 10.2.4. Others
  • 10.3. Market Analysis, Insights and Forecast - By Disease Indication
    • 10.3.1. Diabetes
    • 10.3.2. Obesity
    • 10.3.3. Hormone Deficiency
    • 10.3.4. Others
  • 10.4. Market Analysis, Insights and Forecast - By Needle Size
    • 10.4.1. 4 mm
    • 10.4.2. 5 mm
    • 10.4.3. 6 mm
    • 10.4.4. 8 mm
    • 10.4.5. 12 mm
  • 10.5. Market Analysis, Insights and Forecast - By Distribution Channel
    • 10.5.1. Hospital Pharmacy
    • 10.5.2. Retail Pharmacy
    • 10.5.3. Online Pharmacy
  • 10.6. Market Analysis, Insights and Forecast - By Country/Sub-region
    • 10.6.1. South Africa
    • 10.6.2. GCC
    • 10.6.3. Rest of Latin America

11. Competitive Analysis

  • 11.1. Global Market Share Analysis (2024)
  • 11.2. Company Profiles
    • 11.2.1. Novo Nordisk A/S
      • 11.2.1.1. Overview
      • 11.2.1.2. Products & services
      • 11.2.1.3. SWOT Analysis
      • 11.2.1.4. Recent Developments
      • 11.2.1.5. Strategies
      • 11.2.1.6. Financials (Based on Availability)
    • 11.2.2. Embecta Corp.
      • 11.2.2.1. Overview
      • 11.2.2.2. Products & services
      • 11.2.2.3. SWOT Analysis
      • 11.2.2.4. Recent Developments
      • 11.2.2.5. Strategies
      • 11.2.2.6. Financials (Based on Availability)
    • 11.2.3. B. Braun SE
      • 11.2.3.1. Overview
      • 11.2.3.2. Products & services
      • 11.2.3.3. SWOT Analysis
      • 11.2.3.4. Recent Developments
      • 11.2.3.5. Strategies
      • 11.2.3.6. Financials (Based on Availability)
    • 11.2.4. Owen Mumford
      • 11.2.4.1. Overview
      • 11.2.4.2. Products & services
      • 11.2.4.3. SWOT Analysis
      • 11.2.4.4. Recent Developments
      • 11.2.4.5. Strategies
      • 11.2.4.6. Financials (Based on Availability)
    • 11.2.5. BD
      • 11.2.5.1. Overview
      • 11.2.5.2. Products & services
      • 11.2.5.3. SWOT Analysis
      • 11.2.5.4. Recent Developments
      • 11.2.5.5. Strategies
      • 11.2.5.6. Financials (Based on Availability)
    • 11.2.6. Cardinal Health
      • 11.2.6.1. Overview
      • 11.2.6.2. Products & services
      • 11.2.6.3. SWOT Analysis
      • 11.2.6.4. Recent Developments
      • 11.2.6.5. Strategies
      • 11.2.6.6. Financials (Based on Availability)
    • 11.2.7. SOL-Millennium
      • 11.2.7.1. Overview
      • 11.2.7.2. Products & services
      • 11.2.7.3. SWOT Analysis
      • 11.2.7.4. Recent Developments
      • 11.2.7.5. Strategies
      • 11.2.7.6. Financials (Based on Availability)
    • 11.2.8. Terumo Corporation
      • 11.2.8.1. Overview
      • 11.2.8.2. Products & services
      • 11.2.8.3. SWOT Analysis
      • 11.2.8.4. Recent Developments
      • 11.2.8.5. Strategies
      • 11.2.8.6. Financials (Based on Availability)
    • 11.2.9. MTD Medical Technology and Devices S.p.A.
      • 11.2.9.1. Overview
      • 11.2.9.2. Products & services
      • 11.2.9.3. SWOT Analysis
      • 11.2.9.4. Recent Developments
      • 11.2.9.5. Strategies
      • 11.2.9.6. Financials (Based on Availability)
    • 11.2.10. UltiMed, Inc.
      • 11.2.10.1. Overview
      • 11.2.10.2. Products & services
      • 11.2.10.3. SWOT Analysis
      • 11.2.10.4. Recent Developments
      • 11.2.10.5. Strategies
      • 11.2.10.6. Financials (Based on Availability)
    • 11.2.11. Allison Medical, Inc.
      • 11.2.11.1. Overview
      • 11.2.11.2. Products & services
      • 11.2.11.3. SWOT Analysis
      • 11.2.11.4. Recent Developments
      • 11.2.11.5. Strategies
      • 11.2.11.6. Financials (Based on Availability)

List of Tables

  • Table 1: Global Pen Needles Market Revenue (USD billion) Forecast, by Product Type, 2019-2032
  • Table 2: Global Pen Needles Market Revenue (USD billion) Forecast, by Drug Type, 2019-2032
  • Table 3: Global Pen Needles Market Revenue (USD billion) Forecast, by Needle Size, 2019-2032
  • Table 4: Global Pen Needles Market Revenue (USD billion) Forecast, by Disease Indication, 2019-2032
  • Table 5: Global Pen Needles Market Revenue (USD billion) Forecast, by Distribution Channel, 2019-2032
  • Table 6: Global Pen Needles Market Revenue (USD billion) Forecast, by Region, 2019-2032
  • Table 7: North America Pen Needles Market Revenue (USD billion) Forecast, by Product Type, 2019-2032
  • Table 8: North America Pen Needles Market Revenue (USD billion) Forecast, by Drug Type, 2019-2032
  • Table 9: North America Pen Needles Market Revenue (USD billion) Forecast, by Needle Size, 2019-2032
  • Table 10: North America Pen Needles Market Revenue (USD billion) Forecast, by Disease Indication, 2019-2032
  • Table 11: North America Pen Needles Market Revenue (USD billion) Forecast, by Distribution Channel, 2019-2032
  • Table 12: North America Pen Needles Market Revenue (USD billion) Forecast, By Country, 2019-2032
  • Table 13: Europe Pen Needles Market Revenue (USD billion) Forecast, by Product Type, 2019-2032
  • Table 14: Europe Pen Needles Market Revenue (USD billion) Forecast, by Drug Type, 2019-2032
  • Table 15: Europe Pen Needles Market Revenue (USD billion) Forecast, by Needle Size, 2019-2032
  • Table 16: Europe Pen Needles Market Revenue (USD billion) Forecast, by Disease Indication, 2019-2032
  • Table 17: Europe Pen Needles Market Revenue (USD billion) Forecast, by Distribution Channel, 2019-2032
  • Table 18: Europe Pen Needles Market Revenue (USD billion) Forecast, By Country/ Sub-region, 2019-2032
  • Table 19: Asia Pacific Pen Needles Market Revenue (USD billion) Forecast, by Product Type, 2019-2032
  • Table 20: Asia Pacific Pen Needles Market Revenue (USD billion) Forecast, by Drug Type, 2019-2032
  • Table 21: Asia Pacific Pen Needles Market Revenue (USD billion) Forecast, by Needle Size, 2019-2032
  • Table 22: Asia Pacific Pen Needles Market Revenue (USD billion) Forecast, by Disease Indication, 2019-2032
  • Table 23: Asia Pacific Pen Needles Market Revenue (USD billion) Forecast, by Distribution Channel, 2019-2032
  • Table 24: Asia Pacific Pen Needles Market Revenue (USD billion) Forecast, By Country/ Sub-region, 2019-2032
  • Table 25: Latin America Pen Needles Market Revenue (USD billion) Forecast, by Product Type, 2019-2032
  • Table 26: Latin America Pen Needles Market Revenue (USD billion) Forecast, by Drug Type, 2019-2032
  • Table 27: Latin America Pen Needles Market Revenue (USD billion) Forecast, by Needle Size, 2019-2032
  • Table 28: Latin America Pen Needles Market Revenue (USD billion) Forecast, by Disease Indication, 2019-2032
  • Table 29: Latin America Pen Needles Market Revenue (USD billion) Forecast, by Distribution Channel, 2019-2032
  • Table 30: Latin America Pen Needles Market Revenue (USD billion) Forecast, By Country/ Sub-region, 2019-2032
  • Table 31: Middle East & Africa Pen Needles Market Revenue (USD billion) Forecast, by Product Type, 2019-2032
  • Table 32: Middle East & Africa Pen Needles Market Revenue (USD billion) Forecast, by Drug Type, 2019-2032
  • Table 33: Middle East & Africa Pen Needles Market Revenue (USD billion) Forecast, by Needle Size, 2019-2032
  • Table 34: Middle East & Africa Pen Needles Market Revenue (USD billion) Forecast, by Disease Indication, 2019-2032
  • Table 35: Middle East & Africa Pen Needles Market Revenue (USD billion) Forecast, by Distribution Channel, 2019-2032
  • Table 36: Middle East & Africa Pen Needles Market Revenue (USD billion) Forecast, By Country/ Sub-region, 2019-2032

List of Figures

  • Figure 1: Global Pen Needles Market Revenue Breakdown (USD billion, %) by Region, 2025 & 2032
  • Figure 2: Global Pen Needles Market Value Share (%), by Product Type, 2025 & 2032
  • Figure 3: Global Pen Needles Market Value Share (%), by Drug Type, 2025 & 2032
  • Figure 4: Global Pen Needles Market Value Share (%), by Needle Size, 2025 & 2032
  • Figure 5: Global Pen Needles Market Value Share (%), by Disease Indication, 2025 & 2032
  • Figure 6: Global Pen Needles Market Value Share (%), by Distribution Channel, 2025 & 2032
  • Figure 7: Global Pen Needles Market Value (USD billion), by Region, 2025 & 2032
  • Figure 8: North America Pen Needles Market Value (USD billion), by Product Type, 2025 & 2032
  • Figure 9: North America Pen Needles Market Value Share (%), by Product Type, 2024
  • Figure 10: North America Pen Needles Market Value (USD billion), by Drug Type, 2025 & 2032
  • Figure 11: North America Pen Needles Market Value Share (%), by Drug Type, 2024
  • Figure 12: North America Pen Needles Market Value (USD billion), by Needle Size, 2025 & 2032
  • Figure 13: North America Pen Needles Market Value Share (%), by Needle Size, 2024
  • Figure 14: North America Pen Needles Market Value (USD billion), by Disease Indication, 2025 & 2032
  • Figure 15: North America Pen Needles Market Value Share (%), by Disease Indication, 2024
  • Figure 16: North America Pen Needles Market Value (USD billion), by Distribution Channel, 2025 & 2032
  • Figure 17: North America Pen Needles Market Value Share (%), by Distribution Channel, 2024
  • Figure 18: North America Pen Needles Market Value (USD billion), By Country, 2025 & 2032
  • Figure 19: North America Pen Needles Market Value Share (%), By Country, 2024
  • Figure 20: Europe Pen Needles Market Value (USD billion), by Product Type, 2025 & 2032
  • Figure 21: Europe Pen Needles Market Value Share (%), by Product Type, 2024
  • Figure 22: Europe Pen Needles Market Value (USD billion), by Drug Type, 2025 & 2032
  • Figure 23: Europe Pen Needles Market Value Share (%), by Drug Type, 2024
  • Figure 24: Europe Pen Needles Market Value (USD billion), by Needle Size, 2025 & 2032
  • Figure 25: Europe Pen Needles Market Value Share (%), by Needle Size, 2024
  • Figure 26: Europe Pen Needles Market Value (USD billion), by Disease Indication, 2025 & 2032
  • Figure 27: Europe Pen Needles Market Value Share (%), by Disease Indication, 2024
  • Figure 28: Europe Pen Needles Market Value (USD billion), by Distribution Channel, 2025 & 2032
  • Figure 29: Europe Pen Needles Market Value Share (%), by Distribution Channel, 2024
  • Figure 30: Europe Pen Needles Market Value (USD billion), By Country/ Sub-region, 2025 & 2032
  • Figure 31: Europe Pen Needles Market Value Share (%), By Country/ Sub-region, 2024
  • Figure 32: Asia Pacific Pen Needles Market Value (USD billion), by Product Type, 2025 & 2032
  • Figure 33: Asia Pacific Pen Needles Market Value Share (%), by Product Type, 2024
  • Figure 34: Asia Pacific Pen Needles Market Value (USD billion), by Drug Type, 2025 & 2032
  • Figure 35: Asia Pacific Pen Needles Market Value Share (%), by Drug Type, 2024
  • Figure 36: Asia Pacific Pen Needles Market Value (USD billion), by Needle Size, 2025 & 2032
  • Figure 37: Asia Pacific Pen Needles Market Value Share (%), by Needle Size, 2024
  • Figure 38: Asia Pacific Pen Needles Market Value (USD billion), by Disease Indication, 2025 & 2032
  • Figure 39: Asia Pacific Pen Needles Market Value Share (%), by Disease Indication, 2024
  • Figure 40: Asia Pacific Pen Needles Market Value (USD billion), by Distribution Channel, 2025 & 2032
  • Figure 41: Asia Pacific Pen Needles Market Value Share (%), by Distribution Channel, 2024
  • Figure 42: Asia Pacific Pen Needles Market Value (USD billion), By Country/ Sub-region, 2025 & 2032
  • Figure 43: Asia Pacific Pen Needles Market Value Share (%), By Country/ Sub-region, 2024
  • Figure 44: Latin America Pen Needles Market Value (USD billion), by Product Type, 2025 & 2032
  • Figure 45: Latin America Pen Needles Market Value Share (%), by Product Type, 2024
  • Figure 46: Latin America Pen Needles Market Value (USD billion), by Drug Type, 2025 & 2032
  • Figure 47: Latin America Pen Needles Market Value Share (%), by Drug Type, 2024
  • Figure 48: Latin America Pen Needles Market Value (USD billion), by Needle Size, 2025 & 2032
  • Figure 49: Latin America Pen Needles Market Value Share (%), by Needle Size, 2024
  • Figure 50: Latin America Pen Needles Market Value (USD billion), by Disease Indication, 2025 & 2032
  • Figure 51: Latin America Pen Needles Market Value Share (%), by Disease Indication, 2024
  • Figure 52: Latin America Pen Needles Market Value (USD billion), by Distribution Channel, 2025 & 2032
  • Figure 53: Latin America Pen Needles Market Value Share (%), by Distribution Channel, 2024
  • Figure 54: Latin America Pen Needles Market Value (USD billion), By Country/ Sub-region, 2025 & 2032
  • Figure 55: Latin America Pen Needles Market Value Share (%), By Country/ Sub-region, 2024
  • Figure 56: Middle East & Africa Pen Needles Market Value (USD billion), by Product Type, 2025 & 2032
  • Figure 57: Middle East & Africa Pen Needles Market Value Share (%), by Product Type, 2024
  • Figure 58: Middle East & Africa Pen Needles Market Value (USD billion), by Drug Type, 2025 & 2032
  • Figure 59: Middle East & Africa Pen Needles Market Value Share (%), by Drug Type, 2024
  • Figure 60: Middle East & Africa Pen Needles Market Value (USD billion), by Needle Size, 2025 & 2032
  • Figure 61: Middle East & Africa Pen Needles Market Value Share (%), by Needle Size, 2024
  • Figure 62: Middle East & Africa Pen Needles Market Value (USD billion), by Disease Indication, 2025 & 2032
  • Figure 63: Middle East & Africa Pen Needles Market Value Share (%), by Disease Indication, 2024
  • Figure 64: Middle East & Africa Pen Needles Market Value (USD billion), by Distribution Channel, 2025 & 2032
  • Figure 65: Middle East & Africa Pen Needles Market Value Share (%), by Distribution Channel, 2024
  • Figure 66: Middle East & Africa Pen Needles Market Value (USD billion), By Country/ Sub-region, 2025 & 2032
  • Figure 67: Middle East & Africa Pen Needles Market Value Share (%), By Country/ Sub-region, 2024
  • Figure 68: Global Pen Needles Market Share (%), By Company, 2024